Misperceptions And Missteps: Schultz Speaks Out On CDRH Struggles
This article was originally published in The Gray Sheet
Executive Summary
Front-page criticism of FDA's device review process legitimately flags areas where the agency needs more work, though public misperceptions are also at play, says device center director Dan Schultz
You may also be interested in...
A Wild Ride Along The Total Product Life Cycle For Dan Schultz
It might be said that the tenure of Dan Schultz as CDRH director was a roller coaster ride around the total product life cycle
A Wild Ride Along The Total Product Life Cycle For Dan Schultz
It might be said that the tenure of Dan Schultz as CDRH director was a roller coaster ride around the total product life cycle
FDA Aims To Explain Itself Better With New Transparency Task Force
FDA's newly formed transparency task force will try to identify more effective ways to explain controversial agency decisions to the public